Whole exome sequencing identifies de novo heterozygous CAV1 mutations associated with a novel neonatal onset lipodystrophy syndrome

University of Washington Center for Mendelian Genomics

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Despite remarkable progress in identifying causal genes for many types of genetic lipodystrophies in the last decade, the molecular basis of many extremely rare lipodystrophy patients with distinctive phenotypes remains unclear. We conducted whole exome sequencing of the parents and probands from six pedigrees with neonatal onset of generalized loss of subcutaneous fat with additional distinctive phenotypic features and report de novo heterozygous null mutations, c.424C>T (p.Q142*) and c.479_480delTT (p.F160*), in CAV1 in a 7-year-old male and a 3-year-old female of European origin, respectively. Both the patients had generalized fat loss, thin mottled skin and progeroid features at birth. The male patient had cataracts requiring extraction at age 30 months and the female patient had pulmonary arterial hypertension. Dermal fibroblasts of the female patient revealed negligible CAV1 immunofluorescence staining compared to control but there were no differences in the number and morphology of caveolae upon electron microscopy examination. Based upon the similarities in the clinical features of these two patients, previous reports of CAV1 mutations in patients with lipodystrophies and pulmonary hypertension, and similar features seen in CAV1 null mice, we conclude that these variants are the most likely cause of one subtype of neonatal onset generalized lipodystrophy syndrome.

Original languageEnglish (US)
Pages (from-to)1796-1806
Number of pages11
JournalAmerican Journal of Medical Genetics, Part A
Volume167
Issue number8
DOIs
StatePublished - Aug 1 2015

Fingerprint

Exome
Lipodystrophy
Mutation
Pulmonary Hypertension
Congenital Generalized Lipodystrophy
Caveolae
Skin
Cataract Extraction
Subcutaneous Fat
Pedigree
Fluorescent Antibody Technique
Electron Microscopy
Fibroblasts
Parents
Fats
Parturition
Staining and Labeling
Phenotype

Keywords

  • Cataract
  • Caveolin 1
  • Lipodystrophy
  • Progeroid syndrome
  • Pulmonary hypertension

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Whole exome sequencing identifies de novo heterozygous CAV1 mutations associated with a novel neonatal onset lipodystrophy syndrome. / University of Washington Center for Mendelian Genomics.

In: American Journal of Medical Genetics, Part A, Vol. 167, No. 8, 01.08.2015, p. 1796-1806.

Research output: Contribution to journalArticle

@article{f7b3f65430cc4cb2813039ebf2f6343f,
title = "Whole exome sequencing identifies de novo heterozygous CAV1 mutations associated with a novel neonatal onset lipodystrophy syndrome",
abstract = "Despite remarkable progress in identifying causal genes for many types of genetic lipodystrophies in the last decade, the molecular basis of many extremely rare lipodystrophy patients with distinctive phenotypes remains unclear. We conducted whole exome sequencing of the parents and probands from six pedigrees with neonatal onset of generalized loss of subcutaneous fat with additional distinctive phenotypic features and report de novo heterozygous null mutations, c.424C>T (p.Q142*) and c.479_480delTT (p.F160*), in CAV1 in a 7-year-old male and a 3-year-old female of European origin, respectively. Both the patients had generalized fat loss, thin mottled skin and progeroid features at birth. The male patient had cataracts requiring extraction at age 30 months and the female patient had pulmonary arterial hypertension. Dermal fibroblasts of the female patient revealed negligible CAV1 immunofluorescence staining compared to control but there were no differences in the number and morphology of caveolae upon electron microscopy examination. Based upon the similarities in the clinical features of these two patients, previous reports of CAV1 mutations in patients with lipodystrophies and pulmonary hypertension, and similar features seen in CAV1 null mice, we conclude that these variants are the most likely cause of one subtype of neonatal onset generalized lipodystrophy syndrome.",
keywords = "Cataract, Caveolin 1, Lipodystrophy, Progeroid syndrome, Pulmonary hypertension",
author = "{University of Washington Center for Mendelian Genomics} and Abhimanyu Garg and Martin Kircher and {del Campo}, Miguel and Amato, {R. Stephen} and Agarwal, {Anil K.}",
year = "2015",
month = "8",
day = "1",
doi = "10.1002/ajmg.a.37115",
language = "English (US)",
volume = "167",
pages = "1796--1806",
journal = "American Journal of Medical Genetics, Part A",
issn = "1552-4825",
publisher = "Wiley-Liss Inc.",
number = "8",

}

TY - JOUR

T1 - Whole exome sequencing identifies de novo heterozygous CAV1 mutations associated with a novel neonatal onset lipodystrophy syndrome

AU - University of Washington Center for Mendelian Genomics

AU - Garg, Abhimanyu

AU - Kircher, Martin

AU - del Campo, Miguel

AU - Amato, R. Stephen

AU - Agarwal, Anil K.

PY - 2015/8/1

Y1 - 2015/8/1

N2 - Despite remarkable progress in identifying causal genes for many types of genetic lipodystrophies in the last decade, the molecular basis of many extremely rare lipodystrophy patients with distinctive phenotypes remains unclear. We conducted whole exome sequencing of the parents and probands from six pedigrees with neonatal onset of generalized loss of subcutaneous fat with additional distinctive phenotypic features and report de novo heterozygous null mutations, c.424C>T (p.Q142*) and c.479_480delTT (p.F160*), in CAV1 in a 7-year-old male and a 3-year-old female of European origin, respectively. Both the patients had generalized fat loss, thin mottled skin and progeroid features at birth. The male patient had cataracts requiring extraction at age 30 months and the female patient had pulmonary arterial hypertension. Dermal fibroblasts of the female patient revealed negligible CAV1 immunofluorescence staining compared to control but there were no differences in the number and morphology of caveolae upon electron microscopy examination. Based upon the similarities in the clinical features of these two patients, previous reports of CAV1 mutations in patients with lipodystrophies and pulmonary hypertension, and similar features seen in CAV1 null mice, we conclude that these variants are the most likely cause of one subtype of neonatal onset generalized lipodystrophy syndrome.

AB - Despite remarkable progress in identifying causal genes for many types of genetic lipodystrophies in the last decade, the molecular basis of many extremely rare lipodystrophy patients with distinctive phenotypes remains unclear. We conducted whole exome sequencing of the parents and probands from six pedigrees with neonatal onset of generalized loss of subcutaneous fat with additional distinctive phenotypic features and report de novo heterozygous null mutations, c.424C>T (p.Q142*) and c.479_480delTT (p.F160*), in CAV1 in a 7-year-old male and a 3-year-old female of European origin, respectively. Both the patients had generalized fat loss, thin mottled skin and progeroid features at birth. The male patient had cataracts requiring extraction at age 30 months and the female patient had pulmonary arterial hypertension. Dermal fibroblasts of the female patient revealed negligible CAV1 immunofluorescence staining compared to control but there were no differences in the number and morphology of caveolae upon electron microscopy examination. Based upon the similarities in the clinical features of these two patients, previous reports of CAV1 mutations in patients with lipodystrophies and pulmonary hypertension, and similar features seen in CAV1 null mice, we conclude that these variants are the most likely cause of one subtype of neonatal onset generalized lipodystrophy syndrome.

KW - Cataract

KW - Caveolin 1

KW - Lipodystrophy

KW - Progeroid syndrome

KW - Pulmonary hypertension

UR - http://www.scopus.com/inward/record.url?scp=84937970956&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937970956&partnerID=8YFLogxK

U2 - 10.1002/ajmg.a.37115

DO - 10.1002/ajmg.a.37115

M3 - Article

VL - 167

SP - 1796

EP - 1806

JO - American Journal of Medical Genetics, Part A

JF - American Journal of Medical Genetics, Part A

SN - 1552-4825

IS - 8

ER -